Literature DB >> 7695019

Co-morbidity of lifetime psychiatric disorder among male alcoholic patients.

E C Penick1, B J Powell, E J Nickel, S F Bingham, K R Riesenmy, M R Read, J Campbell.   

Abstract

The lifetime co-morbidity of major psychiatric disorders among male alcoholics was examined with the structured Psychiatric Diagnostic Interview (PDI), which was administered to 928 patients undergoing alcoholism treatment at six Veterans Administration Medical Centers. Thirty-eight percent were positive for alcoholism only; 62% fulfilled inclusive lifetime diagnostic criteria for at least one other additional psychiatric syndrome. Thirty percent satisfied criteria for one additional syndrome; 16% for two additional syndromes; 12% for three; and 4% for four or more disorders in addition to alcoholism. Depression and antisocial personality were the most frequently identified co-occurring syndromes (36% and 24%, respectively) followed by drug abuse and mania (17% each). The additional psychiatric syndromes in this sample were clearly not randomly distributed; instead, certain disorders tended to cluster together such as: drug abuse and antisocial personality; mania and depression; depression and anxiety disorder; and schizophrenia and affective disorder. Implications for classification and treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7695019     DOI: 10.1111/j.1530-0277.1994.tb01425.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  13 in total

1.  Clients with substance abuse and mental health concerns: a guide for conducting intake interviews.

Authors:  Christiane Brems; Mark E Johnson; Lorraine L Namyniuk
Journal:  J Behav Health Serv Res       Date:  2002-08       Impact factor: 1.505

2.  The relationship between parental alcoholism and adolescent psychopathology: a systematic examination of parental comorbid psychopathology.

Authors:  Christine McCauley Ohannessian; Victor M Hesselbrock; John Kramer; Samuel Kuperman; Kathleen K Bucholz; Marc A Schuckit; John I Nurnberger
Journal:  J Abnorm Child Psychol       Date:  2004-10

3.  [Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure].

Authors:  J Jage; F Heid
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

4.  Barriers in diagnosing and treating men with depression: a focus group report.

Authors:  Aaron B Rochlen; Debora A Paterniti; Ronald M Epstein; Paul Duberstein; Lindsay Willeford; Richard L Kravitz
Journal:  Am J Mens Health       Date:  2009-05-11

5.  Common variants in HLA-DRA gene are associated with alcohol dependence in two Caucasian samples.

Authors:  Yue Pan; Ke-Sheng Wang; Liang Wang; Long-Yang Wu
Journal:  J Mol Neurosci       Date:  2012-08-14       Impact factor: 3.444

6.  Antisocial Behavioral Syndromes in Adulthood and Alcohol Use Disorder Treatment over Three-Year Follow-Up: Results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Deborah A Dawson; Bridget F Grant
Journal:  J Am Psychiatr Nurses Assoc       Date:  2010-07       Impact factor: 2.385

7.  Childhood depressive symptoms and early onset of alcohol use.

Authors:  Ping Wu; Hector R Bird; Xinhua Liu; Bin Fan; Cordelia Fuller; Sa Shen; Cristiane S Duarte; Glorisa J Canino
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

8.  Opioid therapy in patients with a history of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  Recommended drug treatment strategies for the alcoholic patient.

Authors:  A Schaffer; C A Naranjo
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

10.  The interaction of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery.

Authors:  Brian R Rush; Michael L Dennis; Christy K Scott; Saulo Castel; Rodney R Funk
Journal:  Eval Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.